Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More

Have Democrats filed impeachment articles against Trump over Iran war? Everything you need to know

India, April 8 -- The push to remove President Donald Trump from office has gained attention again, mainly because of his military actions in Iran. Connecticut Democrat John Larson recently said he ha... Read More

Mohammad Rizwan's "0.01% Chance" Speech Goes Viral Amid PSL 2026 Struggles - Watch Video

India, April 8 -- Mohammad Rizwan, leading Rawalpindiz, grabbed everyone's attention after delivering a heartfelt dressing-room speech following his team's rough start in Pakistan Super League 2026. W... Read More

IPL 2026: Kolkata Knight Riders receive big boost as Cameron Green set to bowl against Lucknow Super Giants, says report

New Delhi, April 8 -- Kolkata Knight Riders (KKR) all-rounder Cameron Green is set to bowl in his team's next IPL 2026 match against Lucknow Super Giants (LSG) in Kolkata on Thursday, according to a r... Read More

Dhurandhar 2 box office collection day 21: Ranveer Singh film sees a sharp dip, crosses rRs.r1040 crore

India, April 8 -- Dhurandhar 2 box office collection day 21: Aditya Dhar's spy action thriller has been rewriting the box office history ever since it released in theatres last month on March 19. The ... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More

• ««
• «
• 5073
• 5074
• 5075
• 5076
• 5077
• 5078
• 5079
• 5080
• 5081
• 5082
• »
• »»